비엠에스 | WE DELIVER SCIENCE

HOME >

메일발송

PepMix™
받는 분

받는 이메일은 필수 입력사항입니다.

보내는 분

보내는 분 이름은 필수 입력사항입니다.

보내는 분 이메일은 필수 입력사항입니다.

코멘트
메일 보내기
레이어팝업 닫기
Etc. > Peptide

PepMix™

  • 제품이미지 0
  • 제품이미지 1
  • 제품이미지 0
  • 제품이미지 1
제품용도
T-cell(lymphocyte) assay를 위한 Infectious Disease Antigen-spanning 혹은 mixed epitope peptide pools
브랜드
JPT
개요
- ELISPOT(Enzyme linked ImmunoSpot), ICS(intracellular Cytokine assay) 같은 T-cell assay 실험에서 면역 자극제로 사용하기 위해 관련 peptide pool을 혼합한 제품
- 치료 개발, 면역 모니터링 등을 위한 다양한 종양, 바이러스, 또는 박테리아 관련 항원이 될 수 있는 pool

Related Information

제품자료
AppNotes CoronaAppNotes HIVAppNotes Clinical Grade
제품특징 제품사양 주문정보 최근 본 제품

제품특징

  


High Quality

 

- ISO 9001 규정에 따라 생산 

- 높은 batch간 재현성

- HPLC 정제로 보장된 순도와 동일성

- T-cell 반응의 false-positive을 유발할 수 있는 오염 또는 시퀀스의 삭제 방지를 보장

- 엄격한 ADCF 정책과 낮은 bioburden 공정으로 오염 위험의 최소화



맞춤형 서비스 제공

 

- Peptide pool customizing 서비스 제공



Application

 

- Efficient in vitro stimulation of antigen-specific CD4+ and CD8+ T cells

- For optimization and validation of T-cell assay

- 세포 면역 반응 모니터링

- 백신 효능 테스트

- As positive and negative control

- For T cell epitope mapping

 


 

제품사양

Length/Overlap 15/11 a.a
Purity 70% ~ 95% (LC-MS)
Amount 25 test/vial

주문정보

Cat No. 품명 규격 제조사 제품정보 수량 견적문의
PM-SARS2-RBDMUT01-1 PepMix™ SARS-CoV-2 (S-RBD B.1.1.7) 1 vial containing 15 nmol (appr. 25µg JPT Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 B.1.1.7 (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.1.7, UK) covering the mutation: N501Y for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-SMUT01-1 PepMix™ SARS-CoV-2 (Spike B.1.1.7) 2 vials (one of each subpool JPT Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 B.1.1.7, UK (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.1.7) covering the following mutations: H0069-, V0070-, Y0144-, N0501Y, A0570D, D0614G, P0681H, T0716I, S0982A, D1118H. 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-RBDMUT02-1 PepMix™ SARS-CoV-2 (S-RBD B.1.351) 1 vial containing 15 nmol (appr. 25µg JPT Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 Lineage B.1.351, South Africa covering the following mutations: K0417N, E0484K, N0501Y) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-SMUT02-1 PepMix™ SARS-CoV-2 (Spike B.1.351) 2 vials (one of each subpool JPT Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 Lineage B.1.351, South Africa covering the following mutations: D0080A, D0215G, L0242-, A0243-, L0244-, K0417N, E0484K, N0501Y,D614G, A0701V. 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-RBDMUT03-1 PepMix™ SARS-CoV-2 (S-RBD P.1) 1 vial containing 15 nmol (appr. 25µg JPT Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 Lineage P.1, Brazil covering the following mutations: K0417T, E0484K, N0501Y for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-SMUT03-1 PepMix™ SARS-CoV-2 (Spike P.1) 2 vials (one of each subpool JPT Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 P.1, (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage P.1, Brazil) covering the following mutations: L0018F, T0020N, P0026S, D0138Y, R0190S, K0417T, E0484K, N0501Y, D0614G, H0655Y, T1027I, V1176F. 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-RBDMUT04-1 PepMix™ SARS-CoV-2 (S-RBD B.1.429) 1 vial containing 15 nmol (appr. 25µg JPT Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 Lineage B.1.429, LA, CAL covering the following mutation: L0452R for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-SMUT04-1 PepMix™ SARS-CoV-2 (Spike B.1.429) 2 vials (one of each subpool JPT Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 B.1.429, LA, CAL (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.429) covering the following mutations: S0013I, W0152C, L0452R, D0614G. 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-HKU1-NCAP PepMix™ HCoV- HKU1 (NCAP) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 108 peptides derived from a peptide scan through Nucloeprotein NCAP of Human coronavirus HKU1 (HCoV-HKU1) for T cell assays (e.g. ELISPOT) 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-HKU1-S PepMix™ HCoV- HKU1 (Spike Glycoprotein) 2 vials (one of each subpool) containing 15 nmol ( JPT Pool of 327 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus HKU1 (HCoV-HKU1) (isolate N1) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-229E-NCAP PepMix™ HCoV-229E (NCAP) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 95 peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein NCAP of Human coronavirus 229E (HCoV-229E) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-229E-S PepMix™ HCoV-229E (Spike Glycoprotein) 2 vials (one of each subpool) containing 15 nmol ( JPT Pool of 291 peptides (delivered in two subpools of 146 & 145 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P15423) of Human coronavirus 229E (HCoV-229E) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-NL63-NCAP PepMix™ HCoV-NL63 (NCAP) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 92 peptides derived from a peptide scan through Nucleoprotein NCAP of Human coronavirus NL63 (HCoV-NL63) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-NL63-S-1 PepMix™ HCoV-NL63 (Spike Glycoprotein) 2 vials (one of each subpool) containing 15 nmol ( JPT Pool of 337 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus NL63 (HCoV-NL63) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-OC43-NCAP PepMix™ HCoV-OC43 (NCAP) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 110 peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein NCAP of Human coronavirus OC43 (HCoV-OC43) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-OC43-S PepMix™ HCoV-OC43 (Spike Glycoprotein) 2 vials (one of each subpool) containing 15 nmol ( JPT Pool of 336 peptides (delivered in two subpools of 168 peptides each) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P36334) of Human coronavirus OC43 (HCoV-OC43) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-MERS-CoV-S PepMix™ MERS-CoV (Spike Glycoprotein) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 336 peptides (delivered in two subpools of 168 peptides each) derived from a peptide scan through the entire Spike glycoprotein of MERS-CoV (Middle East respiratory syndrome-related coronavirus) for T cell assays (e.g. ELISPOT). Amount: 1 vial containing 15 nmol (appr. 25µg) per peptide 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-CVHSA-S PepMix™ SARS-CoV (Spike Glycoprotein) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 311 peptides (delivered in two subpools of 156 and 155 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV (Severe acute respiratory syndrome coronavirus) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-AP3A PepMix™ SARS-CoV-2 (AP3A) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 66 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein 3a (UniProt: P0DTC3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-CLEAVE+NSP11-1 PepMix™ SARS-CoV-2 (C+NSP11) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 16 peptides derived from Non-structural protein 11 and 15 additional Cleave Sites of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NCAP PepMix™ SARS-CoV-2 (NCAP) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 102 peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt: P0DTC9) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-NCPMUT-1 PepMix™ SARS-CoV-2 (NCPMUT) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 23 peptides derived from a peptide scan through Nucleoprotein (mutated regions) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NS6 PepMix™ SARS-CoV-2 (NS6) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 13 peptides derived from a peptide scan (15mers with 11 aa overlap) through Non-Structural protein 6 (UniProt: P0DTC6) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NS7A PepMix™ SARS-CoV-2 (NS7a) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 28 peptides derived from a peptide scan (15mers with 11 aa overlap) through Non-structural protein 7A (UniProt: P0DTC7) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NS8 PepMix™ SARS-CoV-2 (NS8) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 28 peptides derived from a peptide scan (15mers with 11 aa overlap) through Non-structural protein 8 (UniProt: P0DTC8) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP01 PepMix™ SARS-CoV-2 (Nsp1) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 43 peptides derived from a peptide scan through Host translation inhibitor nsp1 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP10 PepMix™ SARS-CoV-2 (Nsp10) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 32 peptides derived from a peptide scan through Non-structural protein 10 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP12 PepMix™ SARS-CoV-2 (Nsp12) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 231 peptides derived from a peptide scan through RNA-directed RNA Polymerase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP13-1 PepMix™ SARS-CoV-2 (Nsp13) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 148 peptides derived from a peptide scan through Helicase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP14-1 PepMix™ SARS-CoV-2 (Nsp14) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 129 peptides derived from a peptide scan through Guanine-N7 methyltransferase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP15-1 PepMix™ SARS-CoV-2 (Nsp15) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 84 peptides derived from a peptide scan through Uridylate-specific endoribonuclease of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP16-1 PepMix™ SARS-CoV-2 (Nsp16) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 72 peptides derived from a peptide scan through 2'-O-methyltransferase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP02 PepMix™ SARS-CoV-2 (Nsp2) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 157 peptides derived from a peptide scan through Non-structural protein 2 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP03-1 PepMix™ SARS-CoV-2 (Nsp3) 2 vials (one of each subpool) containing 15 nmol ( JPT Pool of 484 peptides (delivered in two subpools of 242 peptides each) derived from a peptide scan through Papain-like proteinase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP04 PepMix™ SARS-CoV-2 (Nsp4) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 123 peptides derived from a peptide scan through Non-structural protein 4 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP05 PepMix™ SARS-CoV-2 (Nsp5) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 74 peptides derived from a peptide scan through RNA-directed 3c-like Proteinase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP06-1 PepMix™ SARS-CoV-2 (Nsp6) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 70 peptides derived from a peptide scan through Non-structural protein 6 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP07 PepMix™ SARS-CoV-2 (Nsp7) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 18 peptides derived from a peptide scan through Non-structural protein 7 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP08-1 PepMix™ SARS-CoV-2 (Nsp8) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 47 peptides derived from a peptide scan through Non-structural protein 8 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-NSP09-1 PepMix™ SARS-CoV-2 (Nsp9) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 26 peptides derived from a peptide scan through Non-structural protein 9 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-ORF10 PepMix™ SARS-CoV-2 (ORF10) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 7 peptides derived from a peptide scan (15mers with 11 aa overlap) through ORF10 Protein (UniProt: A0A663DJA2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-ORF9B PepMix™ SARS-CoV-2 (ORF9B) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein 9b (UniProt: P0DTD2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-SMUT01 PepMix™ SARS-CoV-2 (S B.1.1.7 D614G) 2 vials (one of each subpool) containing 15 nmol ( JPT Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 B.1.1.7, UK (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.1.7) covering the following mutations: HV 69-70 deletion, Y144 deletion, N501Y, A570D, P681H, T716I, S982A, D1118H and additional mutation D614G. 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-S-MUT-1 PepMix™ SARS-CoV-2 (S-MUT) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 4 peptides derived from a peptide scan through Spike glycoprotein (mutated region) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-SARS2-RBDMUT01 PepMix™ SARS-CoV-2 (S-RBD N501Y) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain (mutation: N501Y) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-S-RBD PepMix™ SARS-CoV-2 (S-RBD) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 53 peptides derived from a peptide scan through Receptor Binding Domain of Spike Glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-S PepMix™ SARS-CoV-2 (Spike Glycoprotein) 2 vials (one of each subpool) containing 15 nmol ( JPT Pool of 315 peptides (delivered in two subpools of 158 & 157 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P0DTC2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-VEMP PepMix™ SARS-CoV-2 (VEMP) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 16 peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope small membrane protein (UniProt: P0DTC4) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-VME PepMix™ SARS-CoV-2 (VME1) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 53 peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt: P0DTC5) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
PM-WCPV-Y14 PepMix™ SARS-CoV-2 (Y14) 1 vial containing 15 nmol (appr. 25µg) per peptide JPT Pool of 16 peptides derived from a peptide scan (15mers with 11 aa overlap) through Uncharacterized protein 14 (UniProt: P0DTD3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT). 수량증가수량감소 카트담기 카트담기
견적문의 견적문의
전체선택
PepMix™ SARS-CoV-2 (S-RBD B.1.1.7)
Cat No.
PM-SARS2-RBDMUT01-1
규격
1 vial containing 15 nmol (appr. 25µg
제조사
JPT
제품정보
Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 B.1.1.7 (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.1.7, UK) covering the mutation: N501Y for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Spike B.1.1.7)
Cat No.
PM-SARS2-SMUT01-1
규격
2 vials (one of each subpool
제조사
JPT
제품정보
Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 B.1.1.7, UK (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.1.7) covering the following mutations: H0069-, V0070-, Y0144-, N0501Y, A0570D, D0614G, P0681H, T0716I, S0982A, D1118H.
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (S-RBD B.1.351)
Cat No.
PM-SARS2-RBDMUT02-1
규격
1 vial containing 15 nmol (appr. 25µg
제조사
JPT
제품정보
Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 Lineage B.1.351, South Africa covering the following mutations: K0417N, E0484K, N0501Y) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Spike B.1.351)
Cat No.
PM-SARS2-SMUT02-1
규격
2 vials (one of each subpool
제조사
JPT
제품정보
Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 Lineage B.1.351, South Africa covering the following mutations: D0080A, D0215G, L0242-, A0243-, L0244-, K0417N, E0484K, N0501Y,D614G, A0701V.
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (S-RBD P.1)
Cat No.
PM-SARS2-RBDMUT03-1
규격
1 vial containing 15 nmol (appr. 25µg
제조사
JPT
제품정보
Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 Lineage P.1, Brazil covering the following mutations: K0417T, E0484K, N0501Y for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Spike P.1)
Cat No.
PM-SARS2-SMUT03-1
규격
2 vials (one of each subpool
제조사
JPT
제품정보
Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 P.1, (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage P.1, Brazil) covering the following mutations: L0018F, T0020N, P0026S, D0138Y, R0190S, K0417T, E0484K, N0501Y, D0614G, H0655Y, T1027I, V1176F.
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (S-RBD B.1.429)
Cat No.
PM-SARS2-RBDMUT04-1
규격
1 vial containing 15 nmol (appr. 25µg
제조사
JPT
제품정보
Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain of SARS-CoV-2 Lineage B.1.429, LA, CAL covering the following mutation: L0452R for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Spike B.1.429)
Cat No.
PM-SARS2-SMUT04-1
규격
2 vials (one of each subpool
제조사
JPT
제품정보
Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 B.1.429, LA, CAL (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.429) covering the following mutations: S0013I, W0152C, L0452R, D0614G.
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ HCoV- HKU1 (NCAP)
Cat No.
PM-HKU1-NCAP
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 108 peptides derived from a peptide scan through Nucloeprotein NCAP of Human coronavirus HKU1 (HCoV-HKU1) for T cell assays (e.g. ELISPOT)
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ HCoV- HKU1 (Spike Glycoprotein)
Cat No.
PM-HKU1-S
규격
2 vials (one of each subpool) containing 15 nmol (
제조사
JPT
제품정보
Pool of 327 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus HKU1 (HCoV-HKU1) (isolate N1) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ HCoV-229E (NCAP)
Cat No.
PM-229E-NCAP
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 95 peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein NCAP of Human coronavirus 229E (HCoV-229E) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ HCoV-229E (Spike Glycoprotein)
Cat No.
PM-229E-S
규격
2 vials (one of each subpool) containing 15 nmol (
제조사
JPT
제품정보
Pool of 291 peptides (delivered in two subpools of 146 & 145 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P15423) of Human coronavirus 229E (HCoV-229E) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ HCoV-NL63 (NCAP)
Cat No.
PM-NL63-NCAP
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 92 peptides derived from a peptide scan through Nucleoprotein NCAP of Human coronavirus NL63 (HCoV-NL63) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ HCoV-NL63 (Spike Glycoprotein)
Cat No.
PM-NL63-S-1
규격
2 vials (one of each subpool) containing 15 nmol (
제조사
JPT
제품정보
Pool of 337 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus NL63 (HCoV-NL63) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ HCoV-OC43 (NCAP)
Cat No.
PM-OC43-NCAP
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 110 peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein NCAP of Human coronavirus OC43 (HCoV-OC43) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ HCoV-OC43 (Spike Glycoprotein)
Cat No.
PM-OC43-S
규격
2 vials (one of each subpool) containing 15 nmol (
제조사
JPT
제품정보
Pool of 336 peptides (delivered in two subpools of 168 peptides each) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P36334) of Human coronavirus OC43 (HCoV-OC43) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ MERS-CoV (Spike Glycoprotein)
Cat No.
PM-MERS-CoV-S
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 336 peptides (delivered in two subpools of 168 peptides each) derived from a peptide scan through the entire Spike glycoprotein of MERS-CoV (Middle East respiratory syndrome-related coronavirus) for T cell assays (e.g. ELISPOT). Amount: 1 vial containing 15 nmol (appr. 25µg) per peptide
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV (Spike Glycoprotein)
Cat No.
PM-CVHSA-S
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 311 peptides (delivered in two subpools of 156 and 155 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV (Severe acute respiratory syndrome coronavirus) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (AP3A)
Cat No.
PM-WCPV-AP3A
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 66 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein 3a (UniProt: P0DTC3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (C+NSP11)
Cat No.
PM-WCPV-CLEAVE+NSP11-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 16 peptides derived from Non-structural protein 11 and 15 additional Cleave Sites of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (NCAP)
Cat No.
PM-WCPV-NCAP
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 102 peptides derived from a peptide scan (15mers with 11 aa overlap) through Nucleoprotein (UniProt: P0DTC9) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (NCPMUT)
Cat No.
PM-SARS2-NCPMUT-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 23 peptides derived from a peptide scan through Nucleoprotein (mutated regions) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (NS6)
Cat No.
PM-WCPV-NS6
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 13 peptides derived from a peptide scan (15mers with 11 aa overlap) through Non-Structural protein 6 (UniProt: P0DTC6) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (NS7a)
Cat No.
PM-WCPV-NS7A
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 28 peptides derived from a peptide scan (15mers with 11 aa overlap) through Non-structural protein 7A (UniProt: P0DTC7) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (NS8)
Cat No.
PM-WCPV-NS8
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 28 peptides derived from a peptide scan (15mers with 11 aa overlap) through Non-structural protein 8 (UniProt: P0DTC8) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp1)
Cat No.
PM-WCPV-NSP01
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 43 peptides derived from a peptide scan through Host translation inhibitor nsp1 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp10)
Cat No.
PM-WCPV-NSP10
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 32 peptides derived from a peptide scan through Non-structural protein 10 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp12)
Cat No.
PM-WCPV-NSP12
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 231 peptides derived from a peptide scan through RNA-directed RNA Polymerase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp13)
Cat No.
PM-WCPV-NSP13-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 148 peptides derived from a peptide scan through Helicase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp14)
Cat No.
PM-WCPV-NSP14-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 129 peptides derived from a peptide scan through Guanine-N7 methyltransferase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp15)
Cat No.
PM-WCPV-NSP15-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 84 peptides derived from a peptide scan through Uridylate-specific endoribonuclease of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp16)
Cat No.
PM-WCPV-NSP16-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 72 peptides derived from a peptide scan through 2'-O-methyltransferase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp2)
Cat No.
PM-WCPV-NSP02
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 157 peptides derived from a peptide scan through Non-structural protein 2 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp3)
Cat No.
PM-WCPV-NSP03-1
규격
2 vials (one of each subpool) containing 15 nmol (
제조사
JPT
제품정보
Pool of 484 peptides (delivered in two subpools of 242 peptides each) derived from a peptide scan through Papain-like proteinase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp4)
Cat No.
PM-WCPV-NSP04
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 123 peptides derived from a peptide scan through Non-structural protein 4 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp5)
Cat No.
PM-WCPV-NSP05
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 74 peptides derived from a peptide scan through RNA-directed 3c-like Proteinase of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp6)
Cat No.
PM-WCPV-NSP06-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 70 peptides derived from a peptide scan through Non-structural protein 6 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp7)
Cat No.
PM-WCPV-NSP07
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 18 peptides derived from a peptide scan through Non-structural protein 7 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp8)
Cat No.
PM-WCPV-NSP08-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 47 peptides derived from a peptide scan through Non-structural protein 8 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Nsp9)
Cat No.
PM-WCPV-NSP09-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 26 peptides derived from a peptide scan through Non-structural protein 9 of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (ORF10)
Cat No.
PM-WCPV-ORF10
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 7 peptides derived from a peptide scan (15mers with 11 aa overlap) through ORF10 Protein (UniProt: A0A663DJA2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (ORF9B)
Cat No.
PM-WCPV-ORF9B
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through Protein 9b (UniProt: P0DTD2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (S B.1.1.7 D614G)
Cat No.
PM-SARS2-SMUT01
규격
2 vials (one of each subpool) containing 15 nmol (
제조사
JPT
제품정보
Pool of 315 peptides (delivered in two subpools of 158 and 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 B.1.1.7, UK (Severe Acute Respiratory Syndrome-related coronavirus 2, Lineage B.1.1.7) covering the following mutations: HV 69-70 deletion, Y144 deletion, N501Y, A570D, P681H, T716I, S982A, D1118H and additional mutation D614G.
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (S-MUT)
Cat No.
PM-SARS2-S-MUT-1
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 4 peptides derived from a peptide scan through Spike glycoprotein (mutated region) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (S-RBD N501Y)
Cat No.
PM-SARS2-RBDMUT01
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 53 peptides derived from a peptide scan through Spike glycoprotein - Receptor binding domain (mutation: N501Y) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (S-RBD)
Cat No.
PM-WCPV-S-RBD
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 53 peptides derived from a peptide scan through Receptor Binding Domain of Spike Glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Spike Glycoprotein)
Cat No.
PM-WCPV-S
규격
2 vials (one of each subpool) containing 15 nmol (
제조사
JPT
제품정보
Pool of 315 peptides (delivered in two subpools of 158 & 157 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P0DTC2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (VEMP)
Cat No.
PM-WCPV-VEMP
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 16 peptides derived from a peptide scan (15mers with 11 aa overlap) through Envelope small membrane protein (UniProt: P0DTC4) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (VME1)
Cat No.
PM-WCPV-VME
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 53 peptides derived from a peptide scan (15mers with 11 aa overlap) through Membrane protein (UniProt: P0DTC5) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
PepMix™ SARS-CoV-2 (Y14)
Cat No.
PM-WCPV-Y14
규격
1 vial containing 15 nmol (appr. 25µg) per peptide
제조사
JPT
제품정보
Pool of 16 peptides derived from a peptide scan (15mers with 11 aa overlap) through Uncharacterized protein 14 (UniProt: P0DTD3) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).
수량
수량증가수량감소
카트담기 카트담기
견적문의 견적문의
카트담기 견적문의
카트담기 견적문의

최근 본 제품